Abstract

Infection with Japanese encephalitis virus (JEV) induces high morbidity and mortality, including potentially permanent neurological sequelae. However, the mechanisms by which viruses cross the blood-brain barrier (BBB) and invade into the central nervous system (CNS) remain unclear. Here, we show that extracellular HMGB1 facilitates immune cell transmigration. Furthermore, the migration of immune cells into the CNS dramatically increases during JEV infection which may enhance viral clearance, but paradoxically expedite the onset of Japanese encephalitis (JE). In this study, brain microvascular endothelial cells (BMECs) were utilized for the detection of HMGB1 release, and leucocyte, adhesion, and the integrity of the BBB in vitro. Genetically modified JEV-expressing EGFP (EGFP-JEV) and the BBB model were established to trace JEV-infected immune cell transmigration, which mimics the process of viral neuroinfection. We find that JEV causes HMGB1 release from BMECs while increasing adhesion molecules. Recombinant HMGB1 enhances leukocyte-endothelium adhesion, facilitating JEV-infected monocyte transmigration across endothelia. Thus, JEV successfully utilizes infected monocytes to spread into the brain, expanding inside of the brain, and leading to the acceleration of JE onset, which was facilitated by HMGB1. HMGB1-promoted monocyte transmigration may represent the mechanism of JEV neuroinvasion, revealing potential therapeutic targets.

Highlights

  • Japanese encephalitis virus (JEV) is a mosquito-borne, positivesense single-stranded RNA virus (Misra and Kalita, 2010)

  • human brain microvascular endothelial cell (HBMEC) were infected with JEV at an MOI of 1, and the expression of JEV-E protein was measured by Western blotting

  • These results demonstrate that JEV infection induced upregulation of High-mobility group box 1 (HMGB1) expression in brain microvascular endothelial cell (BMEC)

Read more

Summary

Introduction

Japanese encephalitis virus (JEV) is a mosquito-borne, positivesense single-stranded RNA virus (Misra and Kalita, 2010). JEV is an epidemic virus in the southern and eastern regions of Asia (Solomon et al, 2000; Misra and Kalita, 2010). 20% of JE patients succumb to infection, and 50% of the survivors present with permanent neuropsychiatric sequelae (Solomon et al, 2000; Misra and Kalita, 2010). During JEV infection, dramatic BBB damage occurs, which is associated with Guillain-Barre syndrome (Wang et al, 2020). It is essential to investigate the pathways and mechanisms of JEV neuroinvasion

Methods
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.